8 Investor presentation First three months of 2022 New GLP-1 prescriptions in the U quarter of 2022 Weekly NBRx scripts (‘000) 40 US GLP-1 weekly NBRx prescriptions 30 20 10 0 Apr 2020 Apr 2022 Ozempic ® Rybelsus ® dulaglutide NN Source: IQVIA Xponent, Weekly (ending 8 April 2022) Each data points represents a rolling four-week average. Total GLP-1 scripts co NBRx: New-to-brand prescriptions; TRx: Total prescriptions; NN: Novo Nordisk; Scripts: Prescriptions Note: Class growth calculated as Q1 2022 vs Q1 2021
Download PDF file